NASDAQ:PALI

Palisade Bio Stock Forecast, Price & News

$4.11

+0.18 (+4.58 %)

(As of 06/11/2021 12:00 AM ET)

Add

Compare

Today's Range

$3.96

▼

$4.15

50-Day Range N/A

52-Week Range

$3.00

▼

$16.02

Volume599,649 shs

Average Volume892,358 shs

Market Capitalization$11.84 million

P/E RatioN/A

Dividend YieldN/A

Beta1.81

30 days | 90 days | 365 days | Advanced Chart

Receive PALI News and Ratings via Email

Sign-up to receive the latest news and ratings for Palisade Bio and its competitors with MarketBeat's FREE daily newsletter.

About Palisade Bio

Leading BioSciences, Inc. develops therapeutics to improve human health through therapeutic protection of the gastrointestinal mucosal barrier. The company was founded in 2005 and is based in Carlsbad, California.

Neuralstem Worker Tipped Partner to Trial Results, SEC Says
June 7, 2021 | finance.yahoo.com

Palisade Bio (NASDAQ:PALI) Trading Up 3.9%
June 2, 2021 | americanbankingnews.com

Palisade Bio Hosting Key Opinion Leader Webinar on LB1148, an Oral Serine Protease Inhibitor for Postoperative GI Dysfunction
May 27, 2021 | finance.yahoo.com

Palisade Bio and Newsoara Announce Completion of Phase 2 Study in GI Surgery Study in China
May 27, 2021 | finance.yahoo.com

Palisade Bio Receives FDA Fast Track Designation for LB1148 for Reduction of Adhesions Following Abdominal and Pelvic Surgery
May 27, 2021 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PALI
Previous Symbol
CUSIPN/A
CIKN/A
Webleadingbiosciences.com
Phone858 704 4900
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual Sales$10,000.00
Price / Sales1,183.68
Cash FlowN/A
Price / Cash FlowN/A
Book Value$3.39 per share
Price / Book1.21

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares2,880,000
Market Cap$11.84 million
Next Earnings Date6/18/2021 (Estimated)
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

Medical Sector

1943rd out of 2,099 stocks

Biological Products, Except Diagnostic Industry

193rd out of 198 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Palisade Bio.

0.0 Community Rank

Outperform Votes
Palisade Bio has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Palisade Bio has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about Palisade Bio and other stocks. Vote “Outperform” if you believe PALI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PALI will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Palisade Bio does not currently pay a dividend.
Dividend Growth
Palisade Bio does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Palisade Bio insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 2.11% of the stock of Palisade Bio is held by insiders.
Percentage Held by Institutions
Only 29.02% of the stock of Palisade Bio is held by institutions.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Palisade Bio is -0.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Palisade Bio is -0.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Palisade Bio has a P/B Ratio of 1.21. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Palisade Bio (NASDAQ:PALI) Frequently Asked Questions

What stocks does MarketBeat like better than Palisade Bio?

Wall Street analysts have given Palisade Bio a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Palisade Bio wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Palisade Bio's next earnings date?

Palisade Bio is scheduled to release its next quarterly earnings announcement on Friday, June 18th 2021.
View our earnings forecast for Palisade Bio.

Who are Palisade Bio's key executives?

Palisade Bio's management team includes the following people:

Dr. Thomas M. Hallam Ph.D., CEO & Director
Mr. John J. Rodenrys, Co-Founder, Exec. VP of R&D and CTO
Mr. J. D. Finley, Chief Financial Officer & Principal Financial and Accounting Officer
Ms. Sharon McBrayer, Director of Operations
Mr. Charles C. Wells, Sr. VP of HR (Age 70)
Dr. Michael John Dawson M.D., Chief Medical Officer
Mr. Ryker Willie, Director of Fin. & Controller

Who are some of Palisade Bio's key competitors?

Some companies that are related to Palisade Bio include Enzon Pharmaceuticals (ENZN), Acorda Therapeutics (ACOR), BiondVax Pharmaceuticals (BVXV), PharmaCyte Biotech (PMCB), Titan Pharmaceuticals (TTNP), Mosaic ImmunoEngineering (CPMV), AVAX Technologies (AVXT), Cornwall Resources (CORC), Gamida Cell (GMDA), Gene Biotherapeutics (CRXM), Immatics (IMTX), ImmunityBio (IBRX), Mymetics (MYMX), Neurobiological Technologies (NTII) and Omni Bio Pharmaceutical (OMBP).
View all of PALI's competitors.

What is Palisade Bio's stock symbol?

Palisade Bio trades on the NASDAQ under the ticker symbol "PALI."

How do I buy shares of Palisade Bio?

Shares of PALI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Palisade Bio's stock price today?

One share of PALI stock can currently be purchased for approximately $4.11.

How much money does Palisade Bio make?

Palisade Bio has a market capitalization of $11.84 million and generates $10,000.00 in revenue each year.

What is Palisade Bio's official website?

The official website for Palisade Bio is leadingbiosciences.com.

Where are Palisade Bio's headquarters?

Palisade Bio is headquartered at 20271 Goldenrod Lane, Germantown MD, 20876.

How can I contact Palisade Bio?

Palisade Bio's mailing address is 20271 Goldenrod Lane, Germantown MD, 20876. The company can be reached via phone at 858 704 4900 or via email at [email protected]

This page was last updated on 6/13/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here